TwelveStone Health Partners provides infusion therapy services for patients receiving Actemra (tocilizumab) treatment throughout the Southeast. Our clinical team coordinates directly with your prescribing specialist to help manage scheduling, medication preparation, and in-center monitoring during each appointment. 

With more than 30 infusion centers across TN, KY, GA, MS, and VA, patients receive biologic therapy in comfortable private suites designed for ongoing care and clinical support. 

Contact our team to verify insurance coverage, learn more about scheduling an infusion appointment, or complete the Actemra enrollment form before your visit.

Understanding Actemra (Tocilizumab) Infusion Therapy

Actemra (tocilizumab) is a biologic medication used to help manage inflammation associated with certain autoimmune and inflammatory conditions. During an IV infusion appointment, the medication is administered intravenously in a monitored clinical setting under the supervision of trained infusion professionals.

Actemra infusion therapy is commonly prescribed for adults with moderately to severely active rheumatoid arthritis who have not responded adequately to at least one disease-modifying antirheumatic drug (DMARD). TwelveStone coordinates closely with rheumatologists and specialty providers to administer treatment safely and according to each patient’s prescribed care plan.

What Each Infusion Visit Involves

Each infusion appointment is tailored to the patient’s treatment plan and monitored by the clinical team throughout the visit. 

  • Weight-based medication dosing determined by your prescribing specialist.
  • Infusion administration supervised by registered nurses.
  • Routine monitoring of vital signs during treatment.
  • Ongoing communication with your physician regarding treatment scheduling and follow-up care.

TwelveStone also supports patients receiving infusion therapy for additional inflammatory and autoimmune conditions. Related condition resources, including rheumatoid arthritis and gout support pages, are available to help patients better understand long-term treatment options.

What to Expect During Your Infusion Visit

Each infusion appointment includes several clinical steps to support medication safety and dosing accuracy. While the infusion itself generally takes about 60 minutes, the total visit may be longer due to intake procedures, medication preparation, and post-treatment observation. Before treatment begins, the care team reviews your current symptoms, vital signs, and treatment history.

Our clinical team follows a consistent protocol for every appointment:

  1. Check-in and intake paperwork.
  2. Weight and vital sign recording.
  3. IV placement and medication preparation.
  4. Infusion administration.
  5. Post-infusion observation and discharge review.

How to Prepare for Your Appointment

Wear comfortable clothing and arrive hydrated to help support IV placement. TwelveStone infusion centers include private suites with Wi-Fi, refreshments, and reclining chairs during treatment appointments.

Some patients report mild fatigue following biologic infusion therapy, so planning a lighter schedule after your appointment may be helpful. If you experience symptoms after treatment, contact your care team promptly.

For more information about TwelveStone facilities and services, visit our Infusion Center page.

Starting Your Actemra Treatment at TwelveStone

Actemra infusion treatment is prescribed by a specialist and administered in a supervised infusion setting. TwelveStone coordinates with rheumatologists and specialty providers to help patients begin treatment safely while meeting insurance and clinical documentation requirements.

Before beginning treatment, patients are typically screened for infections such as tuberculosis and hepatitis, based on physician recommendations. Ongoing lab monitoring may also be required during treatment to evaluate liver function, cholesterol levels, and overall medication response. To help simplify the process, TwelveStone assists with:

  • Benefits verification and prior authorization support.
  • Communication with prescribing specialists and referral offices.
  • Financial counseling and copay assistance navigation.

Patients can use the infusion center locator to find a nearby treatment location and begin the referral process with the support of the TwelveStone care team.

IV Infusion vs. Subcutaneous Injection: What Is the Difference?

Actemra may be administered either as an intravenous (IV) infusion or as a subcutaneous self-injection, depending on the treatment plan recommended by your physician. Factors such as medical history, monitoring needs, insurance coverage, and patient preference may influence which option is prescribed.

Dosing, Monitoring, and Insurance Differences

Dosing Schedule

IV infusions are commonly administered every four weeks and may be weight-based, while subcutaneous injections are typically self-administered on a more frequent schedule.

Insurance Coverage

IV infusions are often billed through medical benefits, whereas injectable medications may be processed through pharmacy benefits or Medicare Part D.

Clinical Monitoring

Infusion appointments include in-center observation by clinical staff, while self-injections are administered independently at home.

In-center Actemra infusion treatment includes registered nurse supervision, which is especially valuable for patients with a history of reactions or treatment anxiety. TwelveStone financial counselors clarify insurance distinctions and help identify your out-of-pocket costs before your first appointment.

Frequently Asked Questions About Actemra Infusion

Most Actemra infusion appointments take approximately two hours from check-in to discharge. The medication infusion itself generally lasts about 60 minutes, while the remaining time includes intake procedures, medication preparation, and post-infusion observation.

Many patients receive Actemra IV infusions once every four weeks, although treatment frequency depends on the prescribing physician’s recommendations, diagnosis, and response to therapy. TwelveStone helps coordinate recurring appointments to support continuity of care.

Before starting biologic infusion therapy, physicians commonly order screening for infections such as tuberculosis and hepatitis. During treatment, periodic bloodwork may also be used to monitor liver function, cholesterol levels, and blood cell counts.

Some patients experience mild fatigue for 24 to 48 hours following infusion therapy. Planning a lighter schedule after treatment may help support recovery. Contact your healthcare provider if you experience severe symptoms, persistent fever, or signs of an allergic reaction.

Actemra infusions administered in a clinical setting are commonly covered through medical insurance benefits, including Medicare Part B in eligible situations. Coverage varies depending on the patient’s insurance plan and treatment requirements. TwelveStone assists patients with benefits verification and prior authorization coordination before treatment begins.

Many patients are able to drive themselves home after treatment. However, individual responses to infusion therapy can vary. Patients who experience dizziness, fatigue, or lightheadedness may prefer to arrange transportation, especially during their first few appointments.

Schedule Your Actemra Infusion Treatment Today

TwelveStone Health Partners provides supervised Actemra infusion treatment across the Southeast through a network of more than 30 infusion centers. From insurance coordination to ongoing infusion support, the clinical team works closely with patients and prescribing specialists throughout the treatment process.

Use the infusion center locator to find a nearby location or contact the TwelveStone team for additional treatment information.